JPWO2022262789A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022262789A5 JPWO2022262789A5 JP2023578035A JP2023578035A JPWO2022262789A5 JP WO2022262789 A5 JPWO2022262789 A5 JP WO2022262789A5 JP 2023578035 A JP2023578035 A JP 2023578035A JP 2023578035 A JP2023578035 A JP 2023578035A JP WO2022262789 A5 JPWO2022262789 A5 JP WO2022262789A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- pharma
- tautomer
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110673571 | 2021-06-17 | ||
| CN202110673571.1 | 2021-06-17 | ||
| PCT/CN2022/099053 WO2022262789A1 (zh) | 2021-06-17 | 2022-06-16 | 一种抗肿瘤化合物及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523422A JP2024523422A (ja) | 2024-06-28 |
| JP2024523422A5 JP2024523422A5 (https=) | 2025-02-19 |
| JPWO2022262789A5 true JPWO2022262789A5 (https=) | 2025-02-19 |
Family
ID=84526879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578035A Pending JP2024523422A (ja) | 2021-06-17 | 2022-06-16 | 抗腫瘍化合物およびその応用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240358848A1 (https=) |
| EP (1) | EP4357348A1 (https=) |
| JP (1) | JP2024523422A (https=) |
| KR (1) | KR20240022626A (https=) |
| CN (1) | CN119604509A (https=) |
| AU (1) | AU2022294861B2 (https=) |
| CA (1) | CA3223304A1 (https=) |
| IL (1) | IL309457A (https=) |
| MX (1) | MX2023015462A (https=) |
| TW (1) | TW202313125A (https=) |
| WO (1) | WO2022262789A1 (https=) |
| ZA (1) | ZA202400544B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114805377A (zh) * | 2021-01-29 | 2022-07-29 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
| KR20250049293A (ko) * | 2022-07-27 | 2025-04-11 | 밍훼이 파마슈티컬 (항저우) 리미티드 | 항체-약물 접합체 및 이의 용도 |
| KR20250111373A (ko) | 2022-11-25 | 2025-07-22 | 밍훼이 파마슈티컬 (항저우) 리미티드 | 항종양 화합물 및 이의 응용 |
| WO2025241867A1 (zh) * | 2024-05-24 | 2025-11-27 | 明慧医药（杭州）有限公司 | 抗b7-h4抗体药物偶联物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| JP2006316040A (ja) | 2005-05-13 | 2006-11-24 | Genentech Inc | Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法 |
| ITMI20061473A1 (it) * | 2006-07-26 | 2008-01-27 | Indena Spa | Derivati della camptotecina ad attivita antitumorale |
| DK2907824T3 (en) * | 2012-10-11 | 2018-07-23 | Daiichi Sankyo Co Ltd | ANTIBODY-drug conjugate |
| TN2018000112A1 (en) * | 2015-10-29 | 2019-10-04 | Novartis Ag | Antibody conjugates comprising toll-like receptor agonist |
| CA3050668C (en) * | 2017-01-17 | 2023-08-15 | Daiichi Sankyo Company, Limited | Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate |
| CN109106951A (zh) * | 2017-08-18 | 2019-01-01 | 四川百利药业有限责任公司 | 一种喜树碱-抗体偶联物 |
| CA3144790A1 (en) * | 2019-06-28 | 2020-12-30 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Antibody-drug conjugate, intermediate thereof, preparation method therefor and application thereof |
| CN112125915A (zh) * | 2019-09-18 | 2020-12-25 | 四川百利药业有限责任公司 | 一种喜树碱衍生物及其偶联物 |
| CN114805377A (zh) * | 2021-01-29 | 2022-07-29 | 明慧医药（杭州）有限公司 | 适用于抗体-药物偶联物的毒素分子 |
-
2022
- 2022-06-16 JP JP2023578035A patent/JP2024523422A/ja active Pending
- 2022-06-16 CN CN202280083620.9A patent/CN119604509A/zh active Pending
- 2022-06-16 CA CA3223304A patent/CA3223304A1/en active Pending
- 2022-06-16 KR KR1020247001831A patent/KR20240022626A/ko active Pending
- 2022-06-16 WO PCT/CN2022/099053 patent/WO2022262789A1/zh not_active Ceased
- 2022-06-16 US US18/570,784 patent/US20240358848A1/en active Pending
- 2022-06-16 MX MX2023015462A patent/MX2023015462A/es unknown
- 2022-06-16 TW TW111122382A patent/TW202313125A/zh unknown
- 2022-06-16 IL IL309457A patent/IL309457A/en unknown
- 2022-06-16 AU AU2022294861A patent/AU2022294861B2/en active Active
- 2022-06-16 EP EP22824264.0A patent/EP4357348A1/en active Pending
-
2024
- 2024-01-16 ZA ZA2024/00544A patent/ZA202400544B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022511351A5 (https=) | ||
| TWI826828B (zh) | 抗her3抗體-藥物結合物及含有其之醫藥及醫藥組成物 | |
| JP7536188B2 (ja) | エキサテカン誘導体及びそのリンカー－ペイロードとコンジュゲート | |
| JP2024081770A (ja) | 抗ｈｅｒ２抗体－薬物コンジュゲート | |
| EP4523704A1 (en) | Camptothecin derivative and ligand-drug conjugate | |
| WO2019050780A1 (en) | COMPOUNDS FOR REDUCING THE VISCOSITY OF BIOLOGICAL FORMULATIONS | |
| JP2020533965A5 (https=) | ||
| JPWO2021147993A5 (https=) | ||
| JPWO2022262789A5 (https=) | ||
| JP2016540826A5 (https=) | ||
| RU2007101074A (ru) | Фармацевтическая противораковая композиция пролина или его производных и противоопухолевого антитела | |
| JPWO2021190583A5 (https=) | ||
| HK40119434A (en) | Camptothecin derivative and ligand-drug conjugate | |
| RU2021110631A (ru) | Конъюгат лиганд-лекарственное средство аналога экзатекана, способ его получения и его применение | |
| TH2101001650A (th) | ลิแกนด์-ดรักคอนจูเกตของสารแอนะล็อกของเอกซาทีแคน, วิธีการเตรียมสำหรับคอนจูเกตนั้น และการประยุกต์ใช้คอนจูเกตดังกล่าว | |
| CA3256942A1 (en) | Camptothecin derivative and ligand-drug conjugate | |
| RU2021110824A (ru) | Конъюгат антитело к b7h3-аналог экзатекана и его применение в медицине | |
| RU2025101032A (ru) | Слитый белок, содержащий антитело против cd73 и il-2, и его применение | |
| CN121949552A (zh) | Anti-cMet抗体、抗体药物偶联物及其制备方法和用途 | |
| JPWO2021093764A5 (https=) |